Detalles de la búsqueda
1.
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Lancet Oncol;
25(3): 376-387, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309282
2.
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy.
Pediatr Blood Cancer;
68(5): e28839, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33258192
3.
A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor.
Biol Blood Marrow Transplant;
21(3): 440-4, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25459642
4.
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Am J Hematol;
90(11): 1021-6, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26242764
5.
Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study.
Lancet Reg Health Am;
33: 100728, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616918
6.
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol.
Blood Adv;
2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625984
7.
Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.
Blood;
128(5): 735-7, 2016 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297791
8.
Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia.
Blood;
126(4): 561-2, 2015 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26206948
9.
IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines.
Front Immunol;
13: 952231, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203573
10.
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective.
Biomedicines;
10(6)2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740427
11.
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
Front Oncol;
11: 634445, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33763368
12.
Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
J Pediatr Hematol Oncol;
32(2): 134-6, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20098333
13.
Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.
Front Oncol;
10: 1594, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32984022
14.
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.
Clin Case Rep;
8(9): 1678-1681, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32983475
15.
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
J Immunother Cancer;
7(1): 154, 2019 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31208461
Resultados
1 -
15
de 15
1
Próxima >
>>